why choose us

Course: Beyond Tumor Control: Balancing Efficacy with Liver Function Preservation and Quality of Life in HCC

CME Credits: 1.50

Released: 2026-10-07

This MedHive™ workshop convenes expert faculty in a case-based, peer-driven format to help interprofessional teams individualize hepatocellular carcinoma (HCC) treatment while preserving hepatic reserve and quality of life. Faculty will translate clinical trial and real-world evidence into practical selection among immune checkpoint inhibitor (ICI)–based regimens for advanced disease, including in patients with impaired liver function or other high-risk features. Throughout, faculty will model multidisciplinary coordination, shared decision-making, and structured monitoring of liver function and treatment-related toxicity across the care continuum.


After completing this activity, the participant should be better able to:


View Full Course